Nanozymes: The Emerging Frontier in Catalytic Nanomaterials and Their Therapeutic Applications.

Ashish Kumar Parashar, Anu Hardenia, Pratibha Bhide, Sunil Kumar Dwivedi, Purvi Chaturvedi, Asraf Khan
{"title":"Nanozymes: The Emerging Frontier in Catalytic Nanomaterials and Their Therapeutic Applications.","authors":"Ashish Kumar Parashar, Anu Hardenia, Pratibha Bhide, Sunil Kumar Dwivedi, Purvi Chaturvedi, Asraf Khan","doi":"10.2174/0126673878406314251127055108","DOIUrl":null,"url":null,"abstract":"<p><p>Artificial nanomaterials known as nanozymes, which possess inherent enzyme-mimetic characteristics, have transformed environmental research, biomedicine, and catalysis. Compared with natural enzymes, nanozymes are advantageous due to their high stability, low cost, and adaptability. They exhibit oxidation, reduction, peroxidation, and superoxide dismutation activities, which are essential for environmental remediation, disease therapy, and biological diagnostics. Recent developments have further broadened their catalytic capabilities. Nanozyme-based biosensors offer high sensitivity and rapid detection of biomarkers for diseases such as cancer, diabetes, and infectious disorders, significantly improving early disease diagnosis. In therapeutics, nanozymes play a critical role in regulating oxidative stress, enabling targeted drug delivery, and supporting antibacterial treatments. Their ability to mimic peroxidase and catalase activities has greatly enhanced photodynamic therapy, immunotherapy, and neuroprotection strategies. Despite these advances, challenges remain in improving catalytic efficiency, biocompatibility, and target specificity. Safe clinical translation requires addressing issues related to immunogenicity, long-term toxicity, and controlled biodegradability. Advances in surface modification, functionalization, and AI-driven nanozyme design have improved selectivity and therapeutic performance. Integrating nanozymes with bioinformatics, artificial intelligence, and nanomedicine has opened new avenues for precision healthcare, including real-time disease monitoring and personalized treatment strategies. This review highlights the transformative impact of nanozymes in industrial and medical applications by examining recent advances, challenges, and future prospects in the field. With continued development, nanozymes have the potential to revolutionize enzyme-based technologies, making them indispensable to modern science and medicine.</p>","PeriodicalId":94352,"journal":{"name":"Recent advances in drug delivery and formulation","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent advances in drug delivery and formulation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0126673878406314251127055108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Artificial nanomaterials known as nanozymes, which possess inherent enzyme-mimetic characteristics, have transformed environmental research, biomedicine, and catalysis. Compared with natural enzymes, nanozymes are advantageous due to their high stability, low cost, and adaptability. They exhibit oxidation, reduction, peroxidation, and superoxide dismutation activities, which are essential for environmental remediation, disease therapy, and biological diagnostics. Recent developments have further broadened their catalytic capabilities. Nanozyme-based biosensors offer high sensitivity and rapid detection of biomarkers for diseases such as cancer, diabetes, and infectious disorders, significantly improving early disease diagnosis. In therapeutics, nanozymes play a critical role in regulating oxidative stress, enabling targeted drug delivery, and supporting antibacterial treatments. Their ability to mimic peroxidase and catalase activities has greatly enhanced photodynamic therapy, immunotherapy, and neuroprotection strategies. Despite these advances, challenges remain in improving catalytic efficiency, biocompatibility, and target specificity. Safe clinical translation requires addressing issues related to immunogenicity, long-term toxicity, and controlled biodegradability. Advances in surface modification, functionalization, and AI-driven nanozyme design have improved selectivity and therapeutic performance. Integrating nanozymes with bioinformatics, artificial intelligence, and nanomedicine has opened new avenues for precision healthcare, including real-time disease monitoring and personalized treatment strategies. This review highlights the transformative impact of nanozymes in industrial and medical applications by examining recent advances, challenges, and future prospects in the field. With continued development, nanozymes have the potential to revolutionize enzyme-based technologies, making them indispensable to modern science and medicine.

纳米酶:催化纳米材料及其治疗应用的新兴前沿。
人造纳米材料被称为纳米酶,它具有固有的酶模拟特性,已经改变了环境研究,生物医学和催化。与天然酶相比,纳米酶具有稳定性高、成本低、适应性强等优点。它们表现出氧化、还原、过氧化和超氧化物突变活性,这对环境修复、疾病治疗和生物诊断至关重要。最近的发展进一步扩大了它们的催化能力。基于纳米酶的生物传感器为癌症、糖尿病和感染性疾病等疾病的生物标志物提供了高灵敏度和快速检测,显著提高了疾病的早期诊断。在治疗学中,纳米酶在调节氧化应激、实现靶向药物递送和支持抗菌治疗方面发挥着关键作用。它们模拟过氧化物酶和过氧化氢酶活性的能力大大增强了光动力治疗、免疫治疗和神经保护策略。尽管取得了这些进展,但在提高催化效率、生物相容性和靶标特异性方面仍存在挑战。安全的临床翻译需要解决与免疫原性、长期毒性和可控的生物降解性相关的问题。表面修饰、功能化和人工智能驱动的纳米酶设计的进步提高了选择性和治疗性能。将纳米酶与生物信息学、人工智能和纳米医学相结合,为精准医疗开辟了新的途径,包括实时疾病监测和个性化治疗策略。本文通过研究纳米酶在该领域的最新进展、挑战和未来前景,重点介绍了纳米酶在工业和医疗应用中的变革性影响。随着不断发展,纳米酶有可能彻底改变基于酶的技术,使其成为现代科学和医学不可或缺的一部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书